USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Epitope Inc.
City: Beaverton
State: OR
Zip+4: 97006
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $194,887.00 4
SBIR Phase II $874,218.00 2

Award List:

DETECTION OF AIDS VIRUS (HTLV-III) BY MONOCLONAL ANTIBODIES

Award Year / Program / Phase: 1986 / SBIR / Phase I
Agency: HHS
Principal Investigator: Denis R Burger , Principal Investigator
Award Amount: $50,000.00

ETHYLTHIORIBOSE: A NEW ANTIFUNGAL AGENT

Award Year / Program / Phase: 1987 / SBIR / Phase I
Agency: HHS
Principal Investigator: Adolph j ferro phd
Award Amount: $50,000.00
Abstract:
The incidence of fungal infections has increased markedly since the advent of broad-spectrum antibiotics, corticosteroids, cancer chemotherapy, and organ transplantation. currently available antifungal agents such as amphotericin b are often avoided clinically because of their severe toxic side… More

DETECTION OF AIDS VIRUS (HTLV-III) BY MONOCLONAL ANTIBODIES

Award Year / Program / Phase: 1988 / SBIR / Phase II
Agency: HHS
Principal Investigator: Denis R Burger , Principal Investigator
Award Amount: $406,000.00
Abstract:
The objective of this proposal is to use mouse monoclonal antibodies to htlv-iii to evaluate the feasibility of detecting htlv antigen expression on t lymphocytes in clinical specimens from patients with lyphadenopathy syndrome and overt aids, and in individuals in high risk groups. this will be… More

A NON-TOXIC NEW DRUG ACTIVE AGAINST GIARDIA IN VIVO.

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
Giardiasis is the most prevalent parasitic disease in the united states and ranks as a leading cause of diarrheal illness worldwide. available drugs for the treatment of giardiasis have undesirable side-effects and may be carcinogenic. we have found that the method by which giardia degrade the… More

RAPID ASSAY FOR HIV-1 ANTIBODIES IN SALIVA

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $44,887.00

RAPID ASSAY FOR HIV-1 ANTIBODIES IN SALIVA

Award Year / Program / Phase: 1991 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $468,218.00
Abstract:
There is a need for an hiv-i antibody test that is specifically designed for field use with saliva and that is rapid, accurate, convenient, and inexpensive. such a test would be especially valuable in work with i.v. drug abusers and prostitutes, where time with the patient is brief and followup is… More